US meningitis deaths climb to 19 as outbreak widens

At least 19 people have died in a widening fungal meningitis outbreak linked to a contaminated steroid, US health officials said Wednesday.

The flare-up has caused 247 cases across 15 states, the reported on its website.

The southern state of Tennessee remains the hardest hit with 61 cases and eight deaths, followed by Michigan with 48 cases and three fatalities.

Other affected states include Indiana, Maryland and Florida.

The tainted steroid—typically injected into the to treat back pain—has been traced to the New England Compounding Center in Massachusetts, which has since shut down its operations and recalled all of its products.

Officials have said that as many as 14,000 people in 23 states could be at risk and that it could be weeks or even months before authorities have a final tally of the infections, due to the disease's long .

The rare strain of the disease, which inflames the protective membranes covering the brain and , requires a lengthy hospital stay and intravenous medications. However, it is not contagious in this form.

add to favorites email to friend print save as pdf

Related Stories

US tainted drug outbreak rises to 185 cases

Oct 12, 2012

The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.

US meningitis outbreak death toll rises to 15

Oct 14, 2012

The death toll from an unprecedented US meningitis outbreak tied to a tainted steroid jumped to 15 after another person died from a fungal form of the disease, health authorities said Saturday.

Tainted drug death toll rises to 14 in US

Oct 11, 2012

The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.

US pharmacy linked to outbreak issues wide recall

Oct 07, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Recommended for you

WHO: Ebola vaccine trials in W. Africa in January

3 hours ago

Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe, a top World Health Organization official ...

Ebola cases rise sharply in western Sierra Leone

3 hours ago

After emerging months ago in eastern Sierra Leone, Ebola is now hitting the western edges of the country where the capital is located with dozens of people falling sick each day, the government said Tuesday. So many people ...

User comments